Kathleen L Poston

@carlaabdelnour @Stanford_Neuro Awesome!

🤔 What plasma biomarker should we use for LBD? Should we apply AD cut-offs, or does LBD require different ones? 🤓 To discover the answers, go to poster 364 and the 🌟amazing🌟 Alena Smith will explain everything you need to know about plasma pTau181 and 217 in LBD #AAIC24

Registration open for the @Stanford_Neuro 12th Annual Breakthroughs in Neurological Care. Join us for this virtual conference on November 9-10th to learn from @StanfordMed experts on behavioral #neurology, neurocritical care & more! #CME #MedEd Register: stanford.cloud-cme.com/neuro2023

Parkinson's Foundation certifies Stanford Movement Disorders Center as a Center of Excellence, joining a network that is setting the highest standard of care for people with Parkinson’s in the U.S. and internationally. #Parkinsons parkinson.org/about-us/news/…

At the NYC premiere of #Still at the Lincoln center. Thank you to the #MJFF for arranging for the #PPMI investigators to attend!

Always honest and insightful. And a call to action to better treat and find a cure for #parkinsons cnn.com/2023/04/30/ent…

A lab test that can tell doctors if someone has Parkinson's disease is a long-sought goal of researchers. There are new tests that are able to detect traces of a key protein that misfolds and gums up specific areas of the brain. cnn.it/43y2PgB

NEW—Identifying ‘hallmark’ Parkinson’s disease protein build-up could aid early detection and pave way for improved diagnosis and treatment , a new study published in @TheLancetNeuro suggests hubs.li/Q01L9X0B0

@StanfordNsurg @StanfordBrain Very proud of our amazing surgical #Parkinsons team! They work together to improve the lives of our patients every day.

Deep brain stimulation (DBS) procedures use leading-edge techniques, increasing your comfort during surgery. Our team has performed nearly 1500 DBS procedures since 1999. They are researching new or improved treatments for Parkinson's disease. #ParkinsonsAwarenessMonth

“This opens a new chapter in the diagnosis of Parkinson’s disease, where we can accurately determine alpha-synuclein pathology in living people, and this catalyzes the field forward toward disease-targeted therapeutic development.” - Kathleen L. Poston, MD, MS @pddoc

What lies ahead for the future of Neuroscience and why is Stanford Medicine built to lead transformation in relevant fields of study? Hear from Frank Longo, MD, PhD, Chair of Neurology and Michael Lim, MD, Chair of Neurosurgery at Stanford Medicine. youtu.be/91_vd_95GAQ

Congratulations to our #CCAD2023 New Vision Investigator Awardee, @christinabyoung! 👏🏻

Wonderful to be included in this @NeurologyToday piece reflecting on the Progress in Early Detection and Treatment of #Alzheimer’s Disease With comments from Liana Apostolova, Randall Bateman, Gil Rabinovici and myself #EndAlz

1/ I'm fortunate to mentor two awesome PhD students who received @NIH F31 awards. These pay about 26K in salary. In NYC, PhD students earn around 46K, leaving a 20K gap. It turns out that I cannot use R01/R21 funding to pay for this gap and have to rely on discretionary funds.

How far would you go to live better, for longer? Join @chrishemsworth in exploring the boundaries of human potential in #LimitlessWithChrisHemsworth, a Disney+ Original series from @NatGeo Nov 16 on @DisneyPlus featuring our very own @ShaBrainMD. Trailer: youtu.be/SJPnK_NgHVI

Very happy to share new work from the @StanfordADRC using the high-throughput & fully-automated Lumipulse platform to measure #Alzheimer blood biomarker🩸 plasma p-tau181 📈 doi.org/10.1186/s13195… @Stanford_Neuro @StanfordBrain #NIAfundedADRC #EndAlz 🧵👇1/4...

congratulations to @JarodRutledge1 and @blehall for describing new fluid biomarker AADC for Parkinson's disease in great collaboration with Kathleen Poston @pddoc. medrxiv.org/cgi/content/sh…

Pre-print alert! Exciting study from @JarodRutledge1 discovering novel biomarkers in people with #Parkinsons #PD Aromatic L-Amino Acid Decarboxylase is a novel fluid biomarker of Parkinson's disease medrxiv.org/content/10.110…

Excited to share our new study in #Parkinson #PD ! Aromatic L-Amino Acid Decarboxylase is a novel fluid biomarker of Parkinson's disease medrxiv.org/content/10.110…

#Stanford_Neuro Dr. Christina Young talking about #Parkinsons dementia at the #SFNS